GL1X · GenesisL1 explorer

Research workbench

Crystal structure of transthyretin in complex with L6

Analyse Crystal structure of transthyretin in complex with L6 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5AYT
Type
protein
Length
230 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
L6Y
Pockets
3 · best druggability 0.33

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1156% helix, 51% strandP02766

Ligands and binding sites

  • L6Y · 2-oxidanyl-6-(phenylcarbonyl)benzo[de]isoquinoline-1,3-dione · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1720.330.7516empty
2670.290.7318empty
3500.290.7615empty

Interfaces

1 interface between chains.

  • A–B · 904 Ų buried · 23 hydrogen bonds · protein-protein

Compared structures

  • 5AYT · Crystal structure of transthyretin in complex with L6 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.